A survey on the prevalence of apathy in elderly people referred to specialized memory centers.


Journal

International journal of geriatric psychiatry
ISSN: 1099-1166
Titre abrégé: Int J Geriatr Psychiatry
Pays: England
ID NLM: 8710629

Informations de publication

Date de publication:
10 2019
Historique:
received: 11 12 2018
accepted: 12 04 2019
pubmed: 18 4 2019
medline: 14 3 2020
entrez: 18 4 2019
Statut: ppublish

Résumé

Apathy is a pervasive neuropsychiatric syndrome in people with neurocognitive and psychiatric disorders. The diagnostic criteria for apathy (DCA) have been revised in 2018. Employing the 2018 DCA, in the present study, we investigated in groups of elderly subjects suffering from different neuropsychiatric disorders (a) the apathy prevalence; (b) the most commonly affected apathy dimensions (behavior/cognition, emotion, and social interaction); (c) the sensitivity and specificity of those dimensions for apathy diagnosis; and (d) the concurrent validity of 2018 DCA compared with the 2009 DCA. This multicenter survey included 166 subjects. Each center checked the presence of apathy in subjects belonging to the following DSM-5 diagnoses: mild neurocognitive disorders (mild NCDs); major NCDs; affective disorders (Aff D); and subjective cognitive decline (SCD). The frequency of apathy varied significantly based on the diagnostic groups (0% of subjects with apathy in the SCD group; 25% in the mild NCD group; 77% in the major NCD group; and 57% in the Aff. D group). All subjects with apathy fulfilled the criteria for the behavior/cognition dimension, 73.1% fulfilled the criteria for the emotion dimension, and 97.4% fulfilled the criteria for the social interaction dimension. Behavior/cognition showed the highest sensitivity, the copresence of emotion and social interaction the highest specificity. The concordance between the 2009 and the 2018 DCA indicated an almost perfect agreement. These results are consistent with previous reports and confirm that the social interaction dimension added to the 2018 DCA is present in most of subjects with apathy referred to specialized memory centers.

Sections du résumé

BACKGROUND
Apathy is a pervasive neuropsychiatric syndrome in people with neurocognitive and psychiatric disorders. The diagnostic criteria for apathy (DCA) have been revised in 2018.
OBJECTIVES
Employing the 2018 DCA, in the present study, we investigated in groups of elderly subjects suffering from different neuropsychiatric disorders (a) the apathy prevalence; (b) the most commonly affected apathy dimensions (behavior/cognition, emotion, and social interaction); (c) the sensitivity and specificity of those dimensions for apathy diagnosis; and (d) the concurrent validity of 2018 DCA compared with the 2009 DCA.
METHODS
This multicenter survey included 166 subjects. Each center checked the presence of apathy in subjects belonging to the following DSM-5 diagnoses: mild neurocognitive disorders (mild NCDs); major NCDs; affective disorders (Aff D); and subjective cognitive decline (SCD).
RESULTS
The frequency of apathy varied significantly based on the diagnostic groups (0% of subjects with apathy in the SCD group; 25% in the mild NCD group; 77% in the major NCD group; and 57% in the Aff. D group). All subjects with apathy fulfilled the criteria for the behavior/cognition dimension, 73.1% fulfilled the criteria for the emotion dimension, and 97.4% fulfilled the criteria for the social interaction dimension. Behavior/cognition showed the highest sensitivity, the copresence of emotion and social interaction the highest specificity. The concordance between the 2009 and the 2018 DCA indicated an almost perfect agreement.
CONCLUSIONS
These results are consistent with previous reports and confirm that the social interaction dimension added to the 2018 DCA is present in most of subjects with apathy referred to specialized memory centers.

Identifiants

pubmed: 30993719
doi: 10.1002/gps.5125
doi:

Types de publication

Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1369-1377

Informations de copyright

© 2019 John Wiley & Sons, Ltd.

Références

Marin R. Apathy: a neuropsychiatric syndrome. J Neuropsychiatry Clin Neurosci. 1991;3(3):243-254.
Levy R, Dubois B. Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Cereb Cortex. 2005;16(7):916-928.
Zhao Q, Tan L, Wang H, et al. The prevalence of neuropsychiatric symptoms in Alzheimer's disease: systematic review and meta-analysis. J Affect Disord. 2016;190:264-271.
den Brok MGHE, van Dalen JW, van Gool WA, Moll van Charante EP, de Bie RMA, Richard E. Apathy in Parkinson's disease: a systematic review and meta-analysis. Mov Disord. 2015 May;30(6):759-769.
Staekenborg S, Su T, van Straaten E, et al. Behavioural and psychological symptoms in vascular dementia; differences between small- and large-vessel disease. J Neurol Neurosurg Psychiatry. 2009;81(5):547-551.
Starkstein S, Pahissa J. Apathy following traumatic brain injury. Psychiatr Clin North Am. 2014;37(1):103-112.
Yuen G, Bhutani S, Lucas B, et al. Apathy in late-life depression: common, persistent, and disabling. Am J Geriatr Psychiatry. 2015;23(5):488-494.
Yazbek H, Norton J, Capdevielle D, et al. The Lille Apathy Rating Scale (LARS): exploring its psychometric properties in schizophrenia. Schizophr Res. 2014;157(1-3):278-284.
Yeager C, Hyer L. Apathy in dementia: relations with depression, functional competence, and quality of life. Psychol Rep. 2008;102(3):718-722.
Matsumoto N, Ikeda M, Fukuhara R, et al. Caregiver burden associated with behavioral and psychological symptoms of dementia in elderly people in the local community. Dement Geriatr Cogn Disord. 2007;23(4):219-224.
Starkstein S, Jorge R, Misrahi R, Robinson R. A prospective longitudinal study of apathy in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2006;77(1):8-11.
van Dalen JW, van Wanrooij LL, Moll van Charante EP, Brayne C, van Gool WA, Richard E. Association of apathy with risk of incident dementia: a systematic review and meta-analysis. JAMA Psychiat. 2018;75(10):1012-1021.
Zhang M, Wang H, Li T, Yu X. Prevalence of neuropsychiatric symptoms across the declining memory continuum: an observational study in a memory clinic setting. Dement Geriatr Cogn Disord. 2012;2(1):200-208.
Ang Y, Lockwood P, Apps M, Muhammed K, Husain M. Distinct subtypes of apathy revealed by the Apathy Motivation Index. PLoS ONE. 2011;12(1):e0169938.
Starkstein S, Petracca G, Chemerinski E, Kremer J. Syndromic validity of apathy in Alzheimer's disease. Am J Psychiatry. 2001;158(6):872-877.
Robert P, Onyike C, Leentjens A, et al. Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders. Eur Psychiatry. 2009;24(2):98-104.
Le Heron C, Apps M, Husain M. The anatomy of apathy: a neurocognitive framework for a motivated behaviour. Neuropsychologia. 2017;118:54-67.
Robert P, Lanctôt K, Agüera-Ortiz L, et al. Revision of the diagnostic criteria for apathy in brain disorders: the 2018 International Consensus Group. Eur Psychiatry. 2018;54:71-76.
Mulin E, Leone E, Dujardin K, et al. Diagnostic criteria for apathy in clinical practice. Int J Geriatr Psychiatry. 2011;26(2):158-165.
Jessen F, Amariglio RE, van Boxtel M, et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease. Alzheimers Dement. 2014;10(6):844-852.
Lanctot KL, Aguera-Ortiz L, Brodaty H, et al. Apathy associated with neurocognitive disorders: recent progress and future directions. Alzheimers Dement. 2017;13(1):84-100.
van Reekum R, Stuss D, Ostrander L. Apathy: why care? J Neuropsychiatry Clin Neurosci. 2005;17(1):7-19.
Ang YS, Lockwood PL, Kienast A, et al. Differential impact of behavioral, social, and emotional apathy on Parkinson's disease. Ann Clin Transl Neurol. 2018;5(10):1286-1291. Published 2018 Aug 14. https://doi.org/10.1002/acn3.626
Radakovic R, Davenport R, Starr JM, Abrahams S. Apathy dimensions in Parkinson's disease. Int J Geriatr Psychiatry. 2018;33(1):151-158.
den Brok MG, van Dalen JW, van Gool WA, Moll van Charante EP, de Bie R, Richard E. Apathy in Parkinson's disease: a systematic review and meta-analysis. Mov Disord. 2015;30(6):759-769.
Benoit M, Berrut G, Doussaint J, et al. Apathy and depression in mild Alzheimer's disease: a cross-sectional study using diagnostic criteria. J Alzheimers Dis. 2012;31(2):325-334.
Robert P, Clairet S, Benoit M, et al. The apathy inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment. Int J Geriatr Psychiatry. 2002;17:1099e105.
Radakovic R, Abrahams S. Developing a new apathy measurement scale: Dimensional Apathy Scale. Psychiatry Res. 2004;219(3):658-663.

Auteurs

Valeria Manera (V)

Université Côte d'Azur, CoBTeK lab, Centre Hospitalier Universitaire de Nice, CMRR, Nice, France.

Roxane Fabre (R)

Université Côte d'Azur, CoBTeK lab, Centre Hospitalier Universitaire de Nice, CMRR, Nice, France.

Florindo Stella (F)

Laboratório de Neurociências LIM27, Departamento e Instituto de Psiquiatria, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
Biosciences Institute, UNESP-Universidade Estadual Paulista, Campus of Rio Claro, São Paulo, Brazil.

Júlia Cunha Loureiro (JC)

Laboratório de Neurociências LIM27, Departamento e Instituto de Psiquiatria, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
Biosciences Institute, UNESP-Universidade Estadual Paulista, Campus of Rio Claro, São Paulo, Brazil.

Luis Agüera-Ortiz (L)

Department of Psychiatry, Instituto de Investigación Sanitaria (imas12), Hospital Universitario 12 de Octubre, CIBERSAM, Madrid, Spain.

Jorge López-Álvarez (J)

Department of Psychiatry, Instituto de Investigación Sanitaria (imas12), Hospital Universitario 12 de Octubre, CIBERSAM, Madrid, Spain.

Cécile Hanon (C)

Psychiatric Department, AP-HP, Regional Resource Center of Old Age Psychiatry Corentin-Celton Hospital, Academic Hospital West Paris, Paris, France.
Paris Descartes University, Sorbonne Paris Cité, Paris, France.

Nicolas Hoertel (N)

Psychiatric Department, AP-HP, Regional Resource Center of Old Age Psychiatry Corentin-Celton Hospital, Academic Hospital West Paris, Paris, France.
Paris Descartes University, Sorbonne Paris Cité, Paris, France.

Pauline Aalten (P)

Department of Psychiatry and Neuropsychology, Maastricht University, School for Mental Health and Neuroscience (MHeNs), Alzheimer Center Limburg, Maastricht, The Netherlands.

Inez Ramakers (I)

Department of Psychiatry and Neuropsychology, Maastricht University, School for Mental Health and Neuroscience (MHeNs), Alzheimer Center Limburg, Maastricht, The Netherlands.

Radia Zeghari (R)

Université Côte d'Azur, CoBTeK lab, Centre Hospitalier Universitaire de Nice, CMRR, Nice, France.

Philippe Robert (P)

Université Côte d'Azur, CoBTeK lab, Centre Hospitalier Universitaire de Nice, CMRR, Nice, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH